Speed is Equity.
Every month your trial slips is runway you don't get back - and a valuation that moves the wrong way.
Run global-scale trials with the lean team you have.
A six-month delay isn't a line item - it's the difference between a strong raise and a dilutive down-round.
- FPI 30% faster. Reach first-patient-in while competitors are still in setup.
- Zero ramp-up. AI-native. Sites and PIs work from day one - no training programs necessary.
- Clean data from day 1. No three-month UAT cycle, no end-of-study cleanup. Immediately audit-ready.
Speed only helps if the timeline is yours to control!
Stop renting access to your own science.
In most biotechs, the CRO holds the admin keys - your data on their servers, your protocol in their ticket queue. Flip it: you own the platform, and the CRO logs into your environment.
- Bring your own CRO. If a vendor slows you down, swap the talent - not the system.
- Total portability. No proprietary data models, no extraction fees. Your data stays yours, your timeline holds.
“If you own the platform, the CRO becomes swappable and you can take back control over your own operations.”
Legacy tooling doesn't just slow you down. It eats your budget.
No more patchwork of point solutions, marked up and passed to you by your CRO.
- One platform, all features. No per-site fees, no per-patient charges, no surprise upsells.
- Operational benefits that add up. Reusable protocol libraries, edit checks, and templates compress build, amendments, and lock - returning runway on every trial.
Faster trials, a stack you own, runway you keep. That's not operational efficiency - it's the months that make your next raise. Speed is equity. Own it.
Run at 5× capacity without 5× headcount.
No deck, no demo theatre. Just your roadmap and how we can help. Let's chat.
